Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives (Q34638027)

3 August 2017

title

Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

Wolf-Henning Boehncke

series ordinal

1

1 reference

3 August 2017

Sandra Boehncke

series ordinal

2

1 reference

3 August 2017

publication date

1 August 2012

1 reference

Current Rheumatology Reports

3 August 2017

published in

1 reference

3 August 2017

volume

14

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

343-348

1 reference

Resolved psoriasis lesions retain expression of a subset of disease-related genes

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Chronic inflammatory diseases and cardiovascular risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Psoriasis: a possible risk factor for development of coronary artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Managing comorbid disease in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Psoriasis patients show signs of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Serum leptin levels, skin leptin and leptin receptor expression in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Nitric oxide release accounts for insulin's vascular effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Insulin Is an Anti-inflammatory and Anti-atherosclerotic Hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Leptin beyond body weight regulation--current concepts concerning its role in immune function and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Fundamentals of endothelial function for the clinical cardiologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Low adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Chronic plaque psoriasis is associated with increased arterial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Is psoriasis a pre-atherosclerotic disease? Increased insulin resistance and impaired endothelial function in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

AJC editor's consensus: psoriasis and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Development of screening tools to identify psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0260-8

Noninvasive assessment of impaired endothelial function in psoriasis

21 January 2018

1 reference

12 December 2020

Cardiovascular morbidity in psoriatic arthritis

1 reference

12 December 2020

C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy

1 reference

12 December 2020

Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study

1 reference

12 December 2020

The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity

1 reference

12 December 2020

Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study

1 reference

12 December 2020

Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial.

1 reference

12 December 2020

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

1 reference

12 December 2020

Psoriasis: is the impairment to a patient's life cumulative?

1 reference

12 December 2020

Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort

1 reference

12 December 2020

Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis

1 reference

12 December 2020

1 reference

12 December 2020

Risk of Myocardial Infarction in Patients With Psoriasis

1 reference

12 December 2020

Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis

1 reference

12 December 2020

10.1007/S11926-012-0260-8

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1042530297

0 references

1 reference